Back
20 May 2025
The ITA reports that the wrestler Samat Aitpanbet has agreed¹ to the consequences for his anti-doping rule violation (ADRV).
The wrestler tested positive for the prohibited substances drostanolone and clomifene following an in-competition doping control on 12 October 2024 during the World Grappling Championships.
Drostanolone is prohibited under the WADA Prohibited List in the category of S1.1 Anabolic Androgenic Steroids. It is prohibited at all times (in- and out-of-competition) and is classified as a non-specified substance. Drostanolone is a synthetic anabolic steroid which may enhance athletic performance by increasing muscle mass, strength, and overall physical power.
Clomifene is prohibited at all times in the category of S4.2 Hormone and Metabolic Modulators – Anti-Estrogenic substances, and is classified as a specified substance.
On 3 December 2024, when notified about the case, the wrestler was provisionally suspended with immediate effect.²
The wrestler did not challenge the ADRV and agreed with the consequences proposed by the ITA. Due to his early admission, the wrestler was entitled to a one-year reduction of the otherwise four-year period of ineligibility usually imposed for an ADRV for the presence of a non-specified substance like drostanolone as set forth in article 10.8.1 of the UWW anti-doping rules.³ Accordingly, the case was resolved via an acceptance of consequences.
The wrestler’s period of ineligibility is from 3 December 2024 until 2 December 2027. In addition, his individual results obtained at the 2024 World Grappling Championships and other competitive results from 12 October 2024 onwards are disqualified.
Parties with a right of appeal may challenge the decisions before the appeal division of CAS in accordance with article 13.3.2 of the UWW ADR.
The ITA will not comment further on this case.
¹ Athletes have the right to choose not to have their case referred to a hearing panel. In these instances, the anti-doping organisation will assess the athlete’s case file and establish the applicable consequences pursuant to the anti-doping rules and the athlete will have the right to accept the proposed consequences. If the athlete refuses the proposed consequences, the case is transferred to a hearing panel. This resolution mechanism is provided for in articles 8.3.1 and 8.3.3 of the UWW anti-doping rules and 8.3 of the World Anti-Doping Code and is commonly referred to as an agreement on consequences and is deemed a UWW/ITA decision. The athlete’s National Anti-Doping Organisation and the World Anti-Doping Agency have the right to appeal the agreement on consequences before the competent appeal body.
² The information about the Provisional Suspension was publicly disclosed by the ITA shortly after its imposition: https://ita.sport/sanction/united-world-wrestling-uww/
³ Article 10.8.1 of the UWW ADR (and World Anti-Doping Code) provides for a one-year reduction for certain ADRVs based on early admission and acceptance of sanction. This applies where an athlete after being notified by UWW/ITA of a potential ADRV that carries an asserted period of Ineligibility of four (4) or more years, admits the violation and accepts the asserted period of Ineligibility no later than twenty (20) days after receiving notice of an ADRV charge. Where the athlete receives the one-year reduction under Article 10.8.1, no further reduction in the period of Ineligibility is allowed.
